Detection of a second outbreak of chilblain‐like lesions during COVID‐19 pandemic through teledermatology

Teledermatology (TD) was previously described as an efficient substitute to in-person visits for COVID-19 associated lesions. During the first COVID-19 wave, chilblain-like lesions (CLL) were the most reported dermatological manifestation. Although COVID-19 polymerase reactive chain (PCR) or serolog...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the European Academy of Dermatology and Venereology 2021-09, Vol.35 (9), p.e556-e558
Main Authors: Giraud‐Kerleroux, L., Mongereau, M., Cassius, C., Mrad, M., Gary, C., Fiani, C., Ben Kahla, M., Mahevas, T., Zuelgaray, E., Skayem, C., Hua, C., Ezzedine, K., Bagot, M., Bouaziz, J.‐D., Duong, T.A.
Format: Article
Language:English
Subjects:
Covid‐19 Special Forum
Letter To The Editor
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Teledermatology (TD) was previously described as an efficient substitute to in-person visits for COVID-19 associated lesions. During the first COVID-19 wave, chilblain-like lesions (CLL) were the most reported dermatological manifestation. Although COVID-19 polymerase reactive chain (PCR) or serology were negative for most cases, this unexpected outbreak of chilblains remained remarkable. .
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.17378